Simultaneous determination of N-butylscopolamine and oxazepam in pharmaceutical formulations by first-order digital derivative spectrophotometry

A simple method has been developed for the simultaneous determination of N-butylscopolamine bromide and oxazepam in pharmaceutical formulations using first-order digital derivative spectrophotometry. Acetonitrile was selected as the solvent in which both compounds showed well-defined bands. Both analytes showed good stability in this solvent when solutions of the analytes were exposed to light and temperatures between 20 degrees and 80 degrees C. The simultaneous determination of both drugs was performed by the zero-crossing method at 226.0 and 257.0 nm for N-butylscopolamine and oxazepam, respectively. The linear range of determination was found to be 2.5 x 10(-7) to 8.0 x 10(-5) mol/L for N-butylscopolamine and 7.1 x 10(-8) to 8.0 x 10(-5) mol/L for oxazepam. A very good level of repeatability (relative standard deviation) of 0.2% was observed for N-butylscopolamine and oxazepam. The ingredients commonly found in pharmaceutical formulations do not interfere. The proposed method was applied to the determination of these drugs in pharmaceutical formulations (capsules).     

Simultaneous determination of calcium and magnesium by derivative spectrophotometry in pharmaceutical products

First- and second-derivative spectrophotometric methods for the simultaneous determination of calcium and magnesium in their mixtures are described. The methods are based on the colored complexes formed by calcium and magnesium with bromopyrogallol red in presence of Tween 80 as a surfactant. The zero-crossing method has been utilized to measure the first- and second-derivative value of the derivative spectrum. Calcium (0.8-4.8microgml(-1)) is determined in the presence of magnesium (0.5-3.5microgml(-1)) at the pH 10 and vice versa at zero-crossing wavelengths of 544.5 and 570nm in the first-derivative procedure and 574 and 531nm in the second-derivative procedure, respectively. The detection limits achieved were 0.0575microgml(-1) of calcium and 0.03microgml(-1) of magnesium. The relative standard deviations were in all instances less than 2%. The proposed method has been applied to the simultaneous determination of calcium and magnesium in different samples: commercial multivitamin, human serum and drinking water where excellent agreement between reported and obtained results was achieved.     

Simultaneous determination of estradiol and medroxyprogesterone acetate in pharmaceutical formulations by second-derivative spectrophotometry

This paper reports a simple and fast method for the simultaneous determination of estradiol (ED) and medroxyprogesterone acetate (MP) in pharmaceutical formulations by second-derivative spectrophotometry. Methanol was used to extract the drugs from formulations, and subsequently the extracts were evaluated directly by derivative spectrophotometry. The drugs were determined simultaneously by using the graphic method at 297.4 nm for ED and the zero-crossing method at 273.4 nm for MP. If both compounds are present together in a sample, it is possible to quantitate one in the presence of the other. The best signal-to-noise ratio was found when the second derivative of the spectrum was used. The linear ranges for determination of the drugs were 4.7 x 10(-6) to 1.6 x 10(-4) and 7.2 x 10(-6) to 2.0 x 10(-4) mol/L for ED and MP, respectively. The ingredients commonly found in commercial pharmaceutical formulations do not interfere with the determination. Chemical and spectral variables were optimized for the determination of both analytes. Good levels of repeatability (relative standard deviation), 1.4 and 1.9%, were obtained for ED and MP, respectively. The proposed method was applied to the determination of these drugs in pharmaceutical formulations.     

Simultaneous determination of propacetamol and paracetamol by derivative spectrophotometry

The present paper describes a procedure that phenols in air were preconcentrated in a membrane cell and their content was determined by adsorptive polarography. First, the phenols in air samples were preconcentrated in a membrane cell using 2.0 M NaOH solution, then in a pH 1.3 buffer solution p-bromophenylamine forms a diazoate with NaNO(2), and into the mixture the collected phenols were added to form azo-compound in a pH 13 buffer solution. The azo-compound can be adsorbed at the mercury electrode and yields a sensitive oscillopolarographic wave. Over the range 2.0x10(-8)-2.0x10(-5) M, the peak currents are linearly proportional to the concentration of phenols. The detection limit is 5.0x10(-9) M.     

Determination of attapulgite and nifuroxazide in pharmaceutical formulations by sequential digital derivative spectrophotometry

A new method for the sequential determination of attapulgite and nifuroxazide in pharmaceutical formulations by first- and second-derivative spectrophotometry, respectively, has been developed. In order to obtain the optimal conditions for nifuroxazide stability, studies of solvent, light, and temperature effects were performed. The results show that a previous hydrolysis of 2 h in 1.0 x 10(-1)M NaOH solution is necessary in order to obtain stable compounds for analytical purposes. Subsequently, the first- and second-derivative spectra were evaluated directly in the same samples. The sequential determination of the drugs can be performed using the zero-crossing method; the attapulgite determination was carried out using the first derivative at 278.0 nm and the nifuroxazide determination, using the second derivative at 282.0 nm. The determination ranges were 5.7 x 10(-6)-1.0 x 10(-4) and 3.7 x 10(-8) -1.2 x 10(-4)M for attapulgite and nifuroxazide, respectively. Repeatability (relative standard deviation) values of 1.2 and 3.0% were observed for attapulgite and nifuroxazide, respectively. The ingredients commonly found in commercial pharmaceutical formulations do not interfere. The proposed method was applied to the determination of these drugs in tablets. Further, infrared spectroscopy and cyclic voltammetry studies were carried out in order to obtain knowledge of the decomposition products of nifuroxazide.     

Simultaneous determination of pseudoephedrine sulfate, dexbrompheniramine maleate and loratadine in pharmaceutical preparations using derivative spectrophotometry and ratio spectra derivative spectrophotometry

Two new spectrophotometric methods are described for the simultaneous analysis of pseudoephedrine sulfate-dexbrompheniramine maleate (DBP) and pseudoephedrine sulfate-loratadine combinations. In the first, derivative spectrophotometry, dA/dlambda values were read at zero-crossing points. In the second, ratio spectra derivative spectrophotometry, analytical signals were measured at the wavelengths corresponding to either maxima or minima for these drugs in the first derivative spectra of their ratio spectra. The procedures do not require any separation step. Mean recoveries were found to be >99% in the methods for these compounds in their synthetic mixtures. All the spectrophotometric methods proposed were compared with each other and HPLC which was also developed by us and applied to the pharmaceutical preparations selected.     

Simultaneous determination of chlorophyll a and chlorophyll b by derivative spectrophotometry

Chlorophyll a (Chl a) and chlorophyll b (Chl b) plant pigments, which are important in the food industry and are beneficial as environmental pollution indicators, have been extracted with a novel solvent mixture (1:1 v/v acetone–propanol) not containing chloroform and simultaneously determined by first-derivative spectrophotometry. The results were statistically compared to those obtained by the ordinary absorption spectrophotometric reference utilizing the principle of additivity of absorbances. The testing of the developed method in synthetic mixtures of Chl a and Chl b and in real plant material samples (grass, spinach, chard, purslane, black cabbage, crisp lettuce, rocket, dill and seaweed) proved successful in that the developed extractive derivative spectrophotometric method was both rapid and precise, and was not dependent on the Chl a/b ratio in contrast to the reference method which was adversely affected by the latter parameter.     

Simultaneous determination of tartrazine and sunset yellow by derivative spectrophotometry and ratio spectra derivative

Two methods for determining Tartrazine and Sunset Yellow in mixtures by first derivative spectrophotometry and by first derivative of the ratio spectra are described. The procedures do not require any separation step. By the first method, the measurements are obtained in the zero-crossing wavelengths and the calibration graphs are linear up to 20 microg/ml of Tartrazine and up to 40 microg/ml of Sunset Yellow. The determinations of Tartrazine and Sunset Yellow are also done by the first derivative of the ratio spectra. The methods are applied for determining both compounds in four commercial food products.     

Simultaneous determination of cyproterone acetate and ethinylestradiol in tablets by derivative spectrophotometry

Derivative spectrophotometry offers a useful approach for the analysis of drugs in multi-component mixtures. In this study a third-derivative spectrophotometric method was used for simultaneous determination of cyproterone acetate and ethinylestradiol using the zero-crossing technique. The measurements were carried out at wavelengths of 316 and 226 nm for cyproterone acetate and ethinylestradiol respectively. The method was found to be linear (r2>0.999) in the range of 0.5-6 mg/100 ml for cyproterone acetate in the presence of 35 microg/100 ml ethinylestsradiol at 316 nm. The same linear correlation (r2>0.999) was obtained in the range of 10-80 microg/100 ml of ethinylestradiol in the presence of 2 mg/100 ml of cyproterone acetate at 226 nm. The limit of determination was 0.5 mg/100 ml and 10 microg/100 ml for cyproterone acetate and ethinylestradiol respectively. The method was successfully applied for simultaneous determination of cyproterone acetate and ethinylestradiol in pharmaceutical preparations without any interferences from excipients.     

Simultaneous determination of toxic metabolites by linear combination derivative spectrophotometry.

A linear combination derivative spectrophotometric method is described. The method overcomes the problem of overlapping in derivative spectrophotometry and allows the maximum use of quantitative information. In addition, the method can be used to increase the selectivity, sensitivity and accuracy of the simultaneous analysis of multicomponent mixtures. The application of the method to the simultaneous determination of bongkrekic acid and toxoflavin, the toxic metabolites produced by Pseudomonas farinofermentans, is described.     

Simultaneous determination of beryllium and aluminium in mixtures using derivative spectrophotometry

The spectrophotometric determination of beryllium and aluminium with 5,8-dihydroxy-1,4-naphthoquinone in the presence of a non-ionic surfactant is reported. Absorption maxima, molar absorptivity and Sandell's Sensitivity of 1:2 (M:L) beryllium and aluminium complexes are, 585 nm and 598 nm, 1.63 x 10(4) l.mole(-1).cm(-1) and 2.04 x 10(4) l.mole(-1).cm(-1), and 0.55 ng/cm(2) and 1.32 ng/cm(2) respectively. Beer's law is obeyed between 7.20-3.96 x 10(2) ng/ml beryllium and 1.08 x 10(1)-1.08 x 10(3) ng/ml aluminium. A method for simultaneous determination of beryllium and aluminium in their mixture using derivative spectra is described. The range 3.6 x 10(1)-3.6 x 10(2) ng/ml beryllium could be determined in the presence of 1.08 x 10(2)-1.08 x 10(3) ng/ml aluminium, and vice versa.     

Assay of cisapride in pharmaceutical formulations by visible spectrophotometry

Three spectrophotometric methods (A-C) for the assay of cisapride (CPD) in pure and dosage forms are described. Method A is based on the oxidative coupling reaction of CPD with 3-methyl-2-benzothiazolinone hydrazone hydrochloride (MBTH) in the presence of ferric chloride to form a coloured species (_max; 565 nm.) Method B is based on the oxidation of CPD with Fe (III) and subsequent chelation of Fe(II) to form a coloured complex with 1,10-phenanthroline (_max: 520 nm). Method C is based on the formation of a coloured charge-transfer complex between CPD and chloranilic acid (_max; 555 nm). Regression analysis of Beer-Lambert plots showed good correlation in the concentration ranges 2.0–32.0, 0.4–6.4 and 25.0–450.0 g/ml for methods A,B and C, respectively. The validity of the proposed methods was tested by analysing pharmaceutical dosage forms containing CPD and the relative standard deviations were within 1.0%     

Assay of cisapride in pharmaceutical formulations by extraction spectrophotometry

Four simple and sensitive spectrophotometric methods (A-D) for the assay of cisapride in pure and dosage forms based on the formation of chloroform soluble ion-associates under specified experimental conditions are described. Four acidic dyes, namely, Suprachen Violet 3B (SV 3B, method A), Erioglaucine A (EG-A, method B), Naphthalene Blue 12 BR (NB-12BR, method C) and Tropaeolin 000 (TP 000, method D) are utilized. The extracts of the ion-associates exhibit absorption maxima at 595, 640, 620 and 500 nm for methods A, B, C and D, respectively. Beer's law and the precision and accuracy of the methods are checked by the UV reference method. The results are reproducible with an accuracy of +/-1.0%. The methods are found to be suitable for the determination of cisapride in the presence of the other ingredients that are usually present in dosage forms.     

Simultaneous square-wave voltammetric determination of acetazolamide and theophylline in pharmaceutical formulations

Simple, rapid, sensitive and low cost voltammetric method for simultaneous determination of acetazolamide and theophylline in pharmaceutical formulations, was developed using a static mercury drop electrode (SMDE). Well-defined voltammetric peaks were obtained at–0.87 and–1.33 V for acetazolamide and–0.21 V (vs. Ag/AgCl) for theophylline in Britton–Robinson (B–R) buffer (pH 2.4). The reduction peak currents are found to be linearly dependent on the concentration for the both drugs. Calibration graphs were obtained over the concentration range 1.98 × 10^–6 to 5.94 × 10^–5 M and 2.0 × 10^–5 to 5.6 × 10^–4 M for acetazolamide and theophylline, respectively. The limits of detection (LOD) and quantitation (LOQ) of the procedure were also presented. Factors such as, pH of supporting electrolyte, equilibrium time, frequency, scan rate and pulse height were optimized. The validated voltammetric method was successfully applied for simultaneous determinations of the two drugs. The procedure does not require any sample pretreatment or timeconsuming separation steps.     

Simultaneous determination of ascorbic acid and acetylsalicylic acid in pharmaceutical formulations

A direct, simple, and practical first-derivative spectrophotometric method is described for simultaneous determination of ascorbic acid and acetylsalicylic acid. The effects of the solvent, excipients, and spectral variables on the analytical signal were investigated. The drugs were determined simultaneously with a 0.01 M methanolic hydrochloric acid solution as the solvent, and the signals were evaluated directly by using the zero-crossing method at 245.0 and 256.0 nm for acetylsalicylic acid and ascorbic acid, respectively. The method allows the simultaneous determinations of acetylsalicylic acid and ascorbic acid in the ranges of 6.6 x 10(-6) to 1.5 x 10(-4)M and 3.4 x 10(-6) to 2.0 x 10(-4)M, respectively, with standard deviation of <2.0%. The proposed method was applied to determinations of these drugs in tablets.     

Simultaneous determination of tartrazine,riboflavine, curcumin and erythrosine by derivative spectrophotometry

A quaternary mixture of Tartrazine (E-102), Riboflavine (E-101), Curcumin (E-100) and Erythrosine (E-127) can be analysed, by means of a previous extraction step using methyl isobutyl ketone (MIBK) as extracting agent, and resolving the binary mixtures obtained in the aqueous and organic phases by derivative spectrophotometry with measurements at the “zero-crossing” wavelengths and by derivative ratio spectra. The established conditions of extraction and the proposed methods have been applied to determine these colorants in several synthetic mixtures with good recoveries.     

Simultaneous determination of furaltadone and chloramphenicol in pharmaceuticals by derivative spectrophotometry and the derivative of the ratio spectra

Two methods for determining furaltadone and chloramphenicol in mixtures by first derivative spectrophotometry and the derivative of the ratio spectra are described. The procedures do not require any separation step. By both methods lower determination and detection limits are obtained. The methods were applied for determining the two compounds in two pharmaceutical products.     

Simultaneous determination of copper and iron by second derivative spectrophotometry using mixtures of ligands

A highly sensitive and selective second derivative spectrophotometric method has been developed for the determination of copper and iron in mixtures. The method is based on the separation of the analytes by liquid-liquid extraction as picrate ion pairs. Iron-picrate, reacts in the organic phase of DCE with 5-phenyl-3-(4-phenyl-2-pyridinyl)-1,2,4-triazine (PPT). Similarly the copper-picrate reacts with 2,9-dimethyl-4,7-diphenyl-1,10-phenantroline (bathocuproine). The extracts were evaluated directly by derivative spectrophotometric measurement, using the zero-crossing approach for determination of copper and graphic method for iron. Iron and copper were thus determined in the ranges 8-120 ng ml(-1) and 8-125 ng ml(-1), respectively, in the presence of one another. The detection limits achieved (3sigma) were 2.9 ng ml(-1) of iron and 2.8 ng ml(-1) of copper. The relative standard deviations were in all instances less than 2.1%. The proposed method was applied to the determination of both analytes in river and tap water and the results were consistent with those provided by the AAS standard method.     

Determination of Simvastatin in tablet formulations by derivative UV spectrophotometry

An investigation of UV spectroscopic methods, i.e. absorbance, 1st and 2nd derivative spectra for the determination of simvastatin in tablet formulations has been undertaken. This work investigated the possible difficulties that might arise due to the presence of UV absorbing excipients and likely presence of degradation products in such assays. We have demonstrated that the presence of ascorbic acid as an excipient causes interference with simple absorbance measurements leading to a gross over-determination of the simvastatin. 1st and 2nd derivative methods appear to eliminate this problem. We have also shown that the degradation product of simvastatin, i.e. simvastatin β-hydroxy acid, having an almost identical spectrum to the parent drug, may cause problems in the UV spectroscopic determination of the drug in degraded samples.